Oxford BioDynamics Plc (LON:OBD – Get Free Report) was down 11.8% during trading on Monday . The stock traded as low as GBX 4.05 ($0.05) and last traded at GBX 4.05 ($0.05). Approximately 4,219,608 shares changed hands during trading, an increase of 371% from the average daily volume of 895,349 shares. The stock had previously closed at GBX 4.59 ($0.06).
Analysts Set New Price Targets
Separately, Shore Capital reiterated a “house stock” rating on shares of Oxford BioDynamics in a research note on Tuesday, June 18th.
View Our Latest Analysis on Oxford BioDynamics
Oxford BioDynamics Stock Down 12.9 %
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- The Most Important Warren Buffett Stock for Investors: His Own
- Analysts See 51% Upside in Coinbase, Is It Time to Buy the Hype?
- What Are Dividend Champions? How to Invest in the Champions
- NVIDIA May Send Chips to Saudi Arabia – Should You Sell the News?
- Best Aerospace Stocks Investing
- 3 Defensive Stock Alternatives to Bonds If Interest Rates Drop
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.